advertisement

HaagStreit

11.13.4 Betablocker and prostaglandin (17)

Showing records 1 to 17

Display all abstracts in classification 11.13.4 Betablocker and prostaglandin

Search within classification 11.13.4 Betablocker and prostaglandin
78811 Efficacy of the combination of carteolol hydrochloride + latanoprost in the treatment of glaucoma and ocular hypertension
Soares RR
Expert Opinion in Pharmacotherapy 2018; 19: 1731-1738
79208 Preservative-free tafluprost/timolol fixed combination: comparative 24-h efficacy administered morning or evening in open-angle glaucoma patients
Konstas AG
Expert Opinion in Pharmacotherapy 2018; 0: 1-8
78356 Changes in adherence and associated factors among patients on newly introduced prostaglandin analog and timolol fixed-combination therapy
Hasebe Y; Kashiwagi K
Patient preference and adherence 2018; 12: 1567-1577
78811 Efficacy of the combination of carteolol hydrochloride + latanoprost in the treatment of glaucoma and ocular hypertension
Razeghinejad MR
Expert Opinion in Pharmacotherapy 2018; 19: 1731-1738
79208 Preservative-free tafluprost/timolol fixed combination: comparative 24-h efficacy administered morning or evening in open-angle glaucoma patients
Katsanos A
Expert Opinion in Pharmacotherapy 2018; 0: 1-8
78356 Changes in adherence and associated factors among patients on newly introduced prostaglandin analog and timolol fixed-combination therapy
Tsumura T
Patient preference and adherence 2018; 12: 1567-1577
79208 Preservative-free tafluprost/timolol fixed combination: comparative 24-h efficacy administered morning or evening in open-angle glaucoma patients
Athanasopoulos GP; Athanasopoulos GP
Expert Opinion in Pharmacotherapy 2018; 0: 1-8
78356 Changes in adherence and associated factors among patients on newly introduced prostaglandin analog and timolol fixed-combination therapy
Suzuki Y
Patient preference and adherence 2018; 12: 1567-1577
79208 Preservative-free tafluprost/timolol fixed combination: comparative 24-h efficacy administered morning or evening in open-angle glaucoma patients
Voudouragkaki IC; Panagiotou ES
Expert Opinion in Pharmacotherapy 2018; 0: 1-8
78356 Changes in adherence and associated factors among patients on newly introduced prostaglandin analog and timolol fixed-combination therapy
Yoshikawa K; Suzumura H
Patient preference and adherence 2018; 12: 1567-1577
79208 Preservative-free tafluprost/timolol fixed combination: comparative 24-h efficacy administered morning or evening in open-angle glaucoma patients
Pagkalidou E; Haidich AB
Expert Opinion in Pharmacotherapy 2018; 0: 1-8
78356 Changes in adherence and associated factors among patients on newly introduced prostaglandin analog and timolol fixed-combination therapy
Maeda T; Takeda R
Patient preference and adherence 2018; 12: 1567-1577
79208 Preservative-free tafluprost/timolol fixed combination: comparative 24-h efficacy administered morning or evening in open-angle glaucoma patients
Giannoulis DA
Expert Opinion in Pharmacotherapy 2018; 0: 1-8
78356 Changes in adherence and associated factors among patients on newly introduced prostaglandin analog and timolol fixed-combination therapy
Saito H
Patient preference and adherence 2018; 12: 1567-1577
79208 Preservative-free tafluprost/timolol fixed combination: comparative 24-h efficacy administered morning or evening in open-angle glaucoma patients
Spathi E; Giannopoulos T
Expert Opinion in Pharmacotherapy 2018; 0: 1-8
78356 Changes in adherence and associated factors among patients on newly introduced prostaglandin analog and timolol fixed-combination therapy
Araie M
Patient preference and adherence 2018; 12: 1567-1577
79208 Preservative-free tafluprost/timolol fixed combination: comparative 24-h efficacy administered morning or evening in open-angle glaucoma patients
Katz LJ
Expert Opinion in Pharmacotherapy 2018; 0: 1-8

Issue 20-1

Select Issue


advertisement

WGC-2021